{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:15:03Z","timestamp":1786994103095,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.mehy.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:15:56Z","timestamp":1537834556000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A prophylactic low-dose aspirin earlier than 12\u202fweeks until delivery should be considered to prevent preeclampsia"],"prefix":"10.1016","volume":"121","author":[{"given":"Jing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2018.08.005_b0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.mehy.2018.08.005_b0010","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10069","key":"10.1016\/j.mehy.2018.08.005_b0015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(17)30184-8","article-title":"Maternal deaths in the UK: pre-eclampsia deaths are avoidable","volume":"389","author":"Shennan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2018.08.005_b0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mehy.2018.08.005_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mehy.2018.08.005_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2018.08.005_b0045","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. Clinical Guideline 107. Available at: <http:\/\/guidance.nice.org.uk\/CG107\/>; 2010 [accessed January 22 2017]."},{"issue":"7","key":"10.1016\/j.mehy.2018.08.005_b0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1701-2163(15)30533-8","article-title":"Hypertension Guideline Committee. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"Magee","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"10.1016\/j.mehy.2018.08.005_b0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0143-4004(83)80043-5","article-title":"Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy","volume":"4","author":"Pijnenborg","year":"1983","journal-title":"Placenta"},{"issue":"9\u201310","key":"10.1016\/j.mehy.2018.08.005_b0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"issue":"7","key":"10.1016\/j.mehy.2018.08.005_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mehy.2018.08.005_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (VEGFR-1\/ Flt-1): a dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"issue":"6","key":"10.1016\/j.mehy.2018.08.005_b0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1469-7580.2002.00063.x","article-title":"Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature","volume":"200","author":"Charnock-Jones","year":"2002","journal-title":"J Anat"},{"issue":"35","key":"10.1016\/j.mehy.2018.08.005_b0080","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"He","year":"1999","journal-title":"J Biol Chem"},{"issue":"Suppl A","key":"10.1016\/j.mehy.2018.08.005_b0085","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"issue":"Suppl A","key":"10.1016\/j.mehy.2018.08.005_b0090","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/plac.1999.0522","article-title":"Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia","volume":"21","author":"Caniggia","year":"2000","journal-title":"Placenta"},{"issue":"9741","key":"10.1016\/j.mehy.2018.08.005_b0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mehy.2018.08.005_b0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2018.08.005_b0105","article-title":"Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis","volume":"61","author":"Salmon","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mehy.2018.08.005_b0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.6215","article-title":"Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study","volume":"32","author":"Haapsamo","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.mehy.2018.08.005_b0115","first-page":"265","article-title":"Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS","volume":"10","author":"Jamal","year":"2012","journal-title":"Iran J Reprod Med"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1469-0705.2000.00009.x","article-title":"Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial","volume":"15","author":"Grab","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.mehy.2018.08.005_b0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","article-title":"Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis","volume":"129","author":"van Vliet","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"9937","key":"10.1016\/j.mehy.2018.08.005_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.mehy.2018.08.005_b0140","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.08.005_b0145","first-page":"CD004734","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","volume":"7","author":"de Jong","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mehy.2018.08.005_b0150","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0155","doi-asserted-by":"crossref","first-page":"66.e1","DOI":"10.1016\/j.ajog.2016.08.036","article-title":"Gastroschisis: mortality risks with each additional week of expectant management","volume":"216","author":"Sparks","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mehy.2018.08.005_b0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.282.4.356","article-title":"Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study","volume":"282","author":"Mills","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.plefa.2003.04.010","article-title":"Eicosanoids in preeclampsia","volume":"70","author":"Walsh","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4 Pt 1","key":"10.1016\/j.mehy.2018.08.005_b0170","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0002-9378(12)80013-5","article-title":"Low-dose aspirin inhibits lipid peroxides and thromboxane but not prostacyclin in pregnant women","volume":"167","author":"Walsh","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"9575","key":"10.1016\/j.mehy.2018.08.005_b0175","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2018.08.005_b0180","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","article-title":"Mode of action of aspirin as a chemopreventive agent","volume":"191","author":"Dovizio","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.mehy.2018.08.005_b0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fimmu.2017.00261","article-title":"Aspirin: the mechanism of action revisited in the context of pregnancy complications","volume":"8","author":"Cadavid","year":"2017","journal-title":"Front Immunol"},{"issue":"42","key":"10.1016\/j.mehy.2018.08.005_b0190","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.0405445101","article-title":"Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial","volume":"101","author":"Chiang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2018.08.005_b0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1590\/S0074-02762005000900009","article-title":"New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins","volume":"100","author":"Gilroy","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.mehy.2018.08.005_b0200","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/jc.2016-2917","article-title":"Preconception low-dose aspirin restores diminished pregnancy and live birth rates in women with low-grade inflammation: a secondary analysis of a randomized trial","volume":"102","author":"Sjaarda","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mehy.2018.08.005_b0205","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.placenta.2015.01.004","article-title":"Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1","volume":"36","author":"Li","year":"2015","journal-title":"Placenta"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.mehy.2018.08.005_b0215","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mehy.2018.08.005_b0220","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","article-title":"Endothelial dysfunction and hypertension","volume":"64","author":"Brandes","year":"2014","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.mehy.2018.08.005_b0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1479164113500680","article-title":"Cellular and molecular mechanisms of endothelial dysfunction in diabetes","volume":"10","author":"Roberts","year":"2013","journal-title":"Diab Vasc Dis Res"},{"issue":"19\u201320","key":"10.1016\/j.mehy.2018.08.005_b0230","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.mehy.2018.08.005_b0240","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/uog.17517","article-title":"Impaired placentation in women with chronic hypertension who develop pre-eclampsia","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0245","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2005.07.049","article-title":"Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia","volume":"195","author":"Ness","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0705907","article-title":"Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action","volume":"143","author":"Taubert","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.mehy.2018.08.005_b0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11906-016-0688-8","article-title":"Effects of Aspirin on Endothelial Function and Hypertension","volume":"18","author":"Dzeshka","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"10.1016\/j.mehy.2018.08.005_b0260","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jacc.2004.08.071","article-title":"Aspirin administered at bedtime, but not on awakening, has an effect on ambulatory blood pressure in hypertensive patients","volume":"46","author":"Hermida","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2018.08.005_b0265","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.mehy.2018.08.005_b0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09537104.2010.509828","article-title":"Physiologic and pathologic changes of platelets in pregnancy","volume":"21","author":"Valera","year":"2010","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.mehy.2018.08.005_b0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00380-010-0054-8","article-title":"Effects of various doses of aspirin on platelet activity and endothelial function","volume":"26","author":"Furuno","year":"2011","journal-title":"Heart Vessels"},{"issue":"2","key":"10.1016\/j.mehy.2018.08.005_b0280","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.mehy.2018.08.005_b0285","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mehy.2018.08.005_b0290","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1542\/peds.2009-0994","article-title":"EPIPAGE Study Group. Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm","volume":"125","author":"Marret","year":"2010","journal-title":"Pediatrics"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718305073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718305073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T11:53:24Z","timestamp":1544183604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718305073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":58,"alternative-id":["S0306987718305073"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.08.005","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prophylactic low-dose aspirin earlier than 12\u202fweeks until delivery should be considered to prevent preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}